121 related articles for article (PubMed ID: 18776129)
1. Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.
Han S; Ritzenthaler JD; Sun X; Zheng Y; Roman J
Am J Respir Cell Mol Biol; 2009 Mar; 40(3):325-31. PubMed ID: 18776129
[TBL] [Abstract][Full Text] [Related]
2. Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.
Rodríguez-Calvo R; Serrano L; Coll T; Moullan N; Sánchez RM; Merlos M; Palomer X; Laguna JC; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2008 Aug; 57(8):2149-57. PubMed ID: 18443198
[TBL] [Abstract][Full Text] [Related]
3. Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure.
Elie-Caille C; Lascombe I; Péchery A; Bittard H; Fauconnet S
Mol Cell Biochem; 2020 Aug; 471(1-2):113-127. PubMed ID: 32519230
[TBL] [Abstract][Full Text] [Related]
4. PPARβ/δ-ANGPTL4 axis mediates the promotion of mono-2-ethylhexyl phthalic acid on MYCN-amplified neuroblastoma development.
Liu Y; Hamid N; Manzoor R; Zhang BF; Liao YL; Wang JX; Pei DS
Sci Total Environ; 2024 Feb; 912():168949. PubMed ID: 38042186
[TBL] [Abstract][Full Text] [Related]
5. GW0742 reduces mast cells degranulation and attenuates neurological impairments via PPAR
Lu W; Huang J; Flores J; Li P; Wang W; Liu S; Zhang JH; Tang J
Exp Neurol; 2024 Feb; 372():114615. PubMed ID: 37995951
[TBL] [Abstract][Full Text] [Related]
6. The PPARβ/δ-AMPK Connection in the Treatment of Insulin Resistance.
Aguilar-Recarte D; Palomer X; Wahli W; Vázquez-Carrera M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445261
[TBL] [Abstract][Full Text] [Related]
7. PPAR{delta} agonism activates fatty acid oxidation via PGC-1{alpha} but does not increase mitochondrial gene expression and function.
Kleiner S; Nguyen-Tran V; Baré O; Huang X; Spiegelman B; Wu Z
J Biol Chem; 2009 Jul; 284(28):18624-33. PubMed ID: 19435887
[TBL] [Abstract][Full Text] [Related]
8. Establishing the Role of PPARβ/δ in Carcinogenesis.
Peters JM; Gonzalez FJ; Müller R
Trends Endocrinol Metab; 2015 Nov; 26(11):595-607. PubMed ID: 26490384
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells.
Smith RW; Coleman JD; Thompson JT; Vanden Heuvel JP
Biochem Biophys Rep; 2016 Dec; 8():395-402. PubMed ID: 28955982
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophy.
Brault JJ; Jespersen JG; Goldberg AL
J Biol Chem; 2010 Jun; 285(25):19460-71. PubMed ID: 20404331
[TBL] [Abstract][Full Text] [Related]
11. PPARβ/δ activation protects against hepatic ischaemia-reperfusion injury.
Qian B; Wang C; Li X; Ma P; Dong L; Shen B; Wu H; Li N; Kang K; Ma Y
Liver Int; 2023 Dec; 43(12):2808-2823. PubMed ID: 37833850
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of testicular embryonal carcinoma cell tumorigenicity by peroxisome proliferator-activated receptor-β/δ- and retinoic acid receptor-dependent mechanisms.
Yao PL; Chen LP; Dobrzański TP; Phillips DA; Zhu B; Kang BH; Gonzalez FJ; Peters JM
Oncotarget; 2015 Nov; 6(34):36319-37. PubMed ID: 26431381
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of Growth 1b Suppresses Peroxisome Proliferator-Activated Receptor-β/δ Expression Through Downregulation of Hypoxia-Inducible Factor 1α in Osteoblast Differentiation.
Qu B; Hong Z; Gong K; Sheng J; Wu HH; Deng SL; Huang G; Ma ZH; Pan XM
DNA Cell Biol; 2016 Apr; 35(4):184-91. PubMed ID: 26849833
[TBL] [Abstract][Full Text] [Related]
14. Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.
Balandaram G; Kramer LR; Kang BH; Murray IA; Perdew GH; Gonzalez FJ; Peters JM
Toxicology; 2016 Jul; 363-364():1-9. PubMed ID: 27427494
[TBL] [Abstract][Full Text] [Related]
15. CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.
Musicant AM; Parag-Sharma K; Gong W; Sengupta M; Chatterjee A; Henry EC; Tsai YH; Hayward MC; Sheth S; Betancourt R; Hackman TG; Padilla RJ; Parker JS; Giudice J; Flaveny CA; Hayes DN; Amelio AL
Cell Rep; 2021 Feb; 34(8):108768. PubMed ID: 33626346
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation attenuates the function of PGC-1alpha.
Rytinki MM; Palvimo JJ
J Biol Chem; 2009 Sep; 284(38):26184-93. PubMed ID: 19625249
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis.
Lei J; Wu L; Zhang N; Liu X; Zhang J; Kuang L; Chen J; Chen Y; Li D; Li Y
Mol Biomed; 2024 May; 5(1):19. PubMed ID: 38782774
[TBL] [Abstract][Full Text] [Related]
18. Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma.
He F; York JP; Burroughs SG; Qin L; Xia J; Chen D; Quigley EM; Webb P; LeSage GD; Xia X
Dig Liver Dis; 2015 Jan; 47(1):62-7. PubMed ID: 25277864
[TBL] [Abstract][Full Text] [Related]
19. 1,5-anhydro-D-fructose induces anti-aging effects on aging-associated brain diseases by increasing 5'-adenosine monophosphate-activated protein kinase activity via the peroxisome proliferator-activated receptor-γ co-activator-1α/brain-derived neurotrophic factor pathway.
Kikuchi K; Otsuka S; Takada S; Nakanishi K; Setoyama K; Sakakima H; Tanaka E; Maruyama I
Aging (Albany NY); 2023 Nov; 15(21):11740-11763. PubMed ID: 37950725
[TBL] [Abstract][Full Text] [Related]
20. Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity.
Nam A; Jain S; Wu C; Campos A; Shepard RM; Yu Z; Reddy JP; Von Schalscha T; Weis SM; Onaitis M; Wettersten HI; Cheresh DA
Cancer Res; 2024 May; 84(10):1630-1642. PubMed ID: 38588407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
